Echocardiography Sub-Study of the Umbilical Cord Milking in Non-Vigorous Infants Trial (MINVI)
- Conditions
- Birth Asphyxia
- Registration Number
- NCT03798093
- Lead Sponsor
- Sharp HealthCare
- Brief Summary
Non-vigorous infants enrolled in the MINVI trial will be approached for consent for ongoing data collection. As part of the data collection, an optional echocardiogram will be performed if the parent consents.
- Detailed Description
Non-vigorous infants enrolled in the MINVI trial will be approached for consent for ongoing data collection. As part of the data collection, an optional echocardiogram will be performed if the parent consents. The consent will have a check box to indicate if they consent to the additional test.
Echocardiographic measurements will be performed on all infants at 12 hours +/- 6 hours of age by our research sonographers who are blinded to infant randomization. Measurements will be taken according to a standard operating procedure to assess systemic blood flow, by superior vena cava (SVC) flow (ml/kg/min), right ventricular output (ml/kg/min), left ventricular output (LVO) (ml/kg/min), measures of left and right ventricular tissue Doppler and strain imaging. These measurements will be performed offline at a later time. Data will be entered into REDCap.
If any structural abnormalities are found, the attending pediatrician will be notified of the abnormal echocardiogram. The consent will clearly state that this echo is not for diagnostic purposes. Any additional studies including an official complete echocardiogram and or cardiology consultation will be left to the discretion of the attending pediatrician, as he/she deems necessary
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 227
• Non-vigorous newborns born between 35-42 weeks gestation.
- Known major congenital or chromosomal anomalies of newborn.
- Known cardiac defects other than small atrial septal defect (ASD), ventricular septal defect (VSD) and patent ductus arteriosus (PDA).
- Complete placental abruption/cutting through the placenta at time of delivery.
- Monochorionic multiples
- Cord anomaly (i.e. cord avulsion or true knot)
- Presence of non-reducible nuchal cord
- Perinatal providers unaware of the protocol
- Incomplete delivery data
- Infants born in extremis, for whom additional treatment will not be offered.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Left Ventricular Output 12 ± 6 hours of life Left ventricular output measurements taken by cardiac ultrasound.
- Secondary Outcome Measures
Name Time Method Neonatal Right Ventricular Output 12 ± 6 hours of life Obtained from the modified short axis view of the neonatal echocardiogram performed at 12 hours of life ± 6 hours.
Neonatal Superior Vena Cava Flow 12 ± 6 hours of life superior vena cava (SVC) flow (Diameter obtained from the infraclavicular view (hybrid view) and doppler assessment from the subcostal view of the neonatal echocardiogram exam performed at 12 hours of life ± 6 hours.
Neonatal Peak Systolic Strain 12 ± 6 hours of life This measurement reflects the deformation (strain) of the heart muscle during systole (the phase of the heartbeat when the heart contracts) relative to its original length. More negative values indicate better myocardial function while values closer to 0 suggest impaired myocardial function.
Neonatal Peak Systolic Velocity 12 ± 6 hours of life Measure of left and right ventricular peak systolic tissue doppler velocity on neonatal echocardiogram performed at 12 hours of life ± 6 hours.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Sharp Mary Birch Hospital for Women and Newborns
🇺🇸San Diego, California, United States
Sharp Mary Birch Hospital for Women and Newborns🇺🇸San Diego, California, United States